Quote | Rakovina Therapeutics Inc. (TSXVC:RKV:CC)
Last: | $0.175 |
---|---|
Change Percent: | 9.37% |
Open: | $0.175 |
Close: | $0.175 |
High: | $0.175 |
Low: | $0.175 |
Volume: | 500 |
Last Trade Date Time: | 05/04/2022 04:56:21 pm |
News | Rakovina Therapeutics Inc. (TSXVC:RKV:CC)
VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce, further to the pres...
VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX.V: RKV), (the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for the ...
Message Board Posts | Rakovina Therapeutics Inc. (TSXVC:RKV:CC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Rakovina Therapeutics Inc. Company Name:
RKV:CC Stock Symbol:
TSXVC Market:
Rakovina Therapeutics Inc. Website:
VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce, further to the pres...
VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX.V: RKV), (the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for the ...
All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“ Rakovina ” or the “ Company ”) (TSX-V: RKV) announces that in accordance with the terms of an indenture ente...